AMBER0 in patients when at least three prior prophylactic treatments have failed and erenumab, galcanezumab or fremanezumab are being considered.
Periodic review by specialist services is necessary to ensure that a patient continues to benefit from treatment with zonisamide.
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist